Energyvet Cytovet: Veterinary Product Profile

Energyvet Cytovet is a named branded product for All animal species according to the manufacturer, including dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

oral capsules; the official English page lists a 90-capsule presentation. Intended species: All animal species according to the manufacturer, including dogs and cats.

The current official English leaflet lists, per capsule, potassium humate 448 mg, gelatin, silymarin 50 mg, and succinic acid 2 mg. These are composition data, not a Directory dosing instruction. The physical label, lot, and country version must still be checked for later changes.

Energyvet markets Cytovet as a humate-based detoxifying and protective product and uses strong statements about tumour growth and metastasis. It also frames the product as part of the company's holistic veterinary approach. These claims describe manufacturer positioning and must not be presented as independently established clinical efficacy.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The current official product page and linked English leaflet verify a named humate, silymarin, and succinic-acid formulation and its current leaflet amounts. No controlled canine or feline oncology trial of the finished Cytovet product was located. Binding or antioxidant theories and ingredient research do not demonstrate tumour response or survival benefit for the finished product.

The manufacturer warns that Cytovet may reduce the effects of cytostatic or chemotherapeutic agents, plausibly through binding, and advises separation in its own use instructions. This Directory does not recreate a timing schedule. Chemotherapy, oral drugs, minerals, poor intake, constipation or diarrhoea, liver or kidney disease, and capsule excipients require veterinary review; the treating team should decide whether use is compatible at all.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The manufacturer presents Cytovet as a veterinary product in the Czech Republic. An authorisation for this exact name was not identified in the current Czech register of authorised veterinary medicinal products, and no EU oncology-medicine authorisation was verified. Its precise non-medicinal national category should be confirmed from the current label.

Czech Republic; European Union

Document the quantitative formula on the supplied label, together with lot, expiry, medicines, and treatment schedule. Track appetite, vomiting, constipation, diarrhoea, stool colour, hydration, weight, activity, and adherence to prescribed therapy. If used near oral medicine or chemotherapy, the oncology team must define timing and monitoring; owners should not infer compatibility from a generic web summary.